Age-dependent methylation of ESR1 gene in prostate cancer

Biochemical and Biophysical Research Communications

Volumn 321, Issue 2, 2004, Pages 455-461

  Li, Long Cheng ^a   Shiina, Hiroaki ^a,b   Deguchi, Masao ^a   Zhao, Hong ^a   Okino, Steven T ^a   Kane, Christopher J ^a   Carroll, Peter R ^a   Igawa, Miko ^b   Dahiya, Rajvir ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SHIMANE UNIVERSITY   (Japan)

Author keywords

Aging; Estrogen receptor; Methylation; Prostate cancer

Indexed keywords

BISULFITE; ESTROGEN RECEPTOR ALPHA; PROSTATE SPECIFIC ANTIGEN; ESTROGEN RECEPTOR;

ADULT; AGED; AGING; ALLELE; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CPG ISLAND; DENSITY; DISEASE SEVERITY; DNA METHYLATION; GENE SEQUENCE; GENETIC CORRELATION; GENOME ANALYSIS; GROUPS BY AGE; HUMAN; HUMAN TISSUE; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; SCORING SYSTEM; CLASSIFICATION; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

AGED; AGING; BASE SEQUENCE; DNA METHYLATION; ESTROGEN RECEPTOR ALPHA; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RECEPTORS, ESTROGEN;

EID: 3242756641     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.06.164     Document Type: Article

References (37)

1. ACS, in: American Cancer Society, Atlanta, GA, 2004, pp. 1-5
2. D.G. Mcleod, Prostate cancer: past, present and future, in: N.A. Dawson, N.J. Vogelzang, (Ed.), Prostate Cancer, Wiley-Liss, New York, 1994, p. 18
3. R.A. DePinho The age of cancer Nature 408 2000 248 254
4. H.J. Sommerfeld, A.K. Meeker, M.A. Piatyszek, G.S. Bova, J.W. Shay and D.S. Coffey Telomerase activity: a prevalent marker of malignant human prostate tissue Cancer Res. 56 1996 218 222
5. W. Zhang, L.R. Kapusta, J.M. Slingerland and L.H. Klotz Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium Cancer Res. 58 1998 619 621
6. J.P. Issa CpG-island methylation in aging and cancer Curr. Top. Microbiol. Immunol. 249 2000 101 118
7. C. Huggins Two principles in endocrine therapy of cancers: hormone deprival and hormone interference Cancer Res. 25 1965 1163 1167
8. D.F. Paulson Management of metastatic prostatic cancer Urology 25 1985 49 52
9. L.A. Castagnetta and G. Carruba Human prostate cancer: a direct role for oestrogens Ciba Found. Symp. 191 1995 269 286 discussion 286-269
10. G. Carruba, U. Pfeffer, E. Fecarotta, D.A. Coviello, E. D'Amato, M. Lo Castro, G. Vidali and L. Castagnetta Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells Cancer Res. 54 1994 1190 1193
11. R.A. Jarred, S.J. McPherson, J.J. Bianco, J.F. Couse, K.S. Korach and G.P. Risbridger Prostate phenotypes in estrogen-modulated transgenic mice Trends Endocrinol. Metab. 13 2002 163 168
12. M. Garcia, D. Derocq, G. Freiss and H. Rochefort Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells Proc. Natl. Acad. Sci. USA 89 1992 11538 11542
13. C.K. Watts, M.G. Parker and R.J. King Stable transfection of the oestrogen receptor gene into a human osteosarcoma cell line J. Steroid Biochem. 34 1989 483 490
14. M.L. Maminta, A. Molteni and S.T. Rosen Stable expression of the human estrogen receptor in HeLa cells by infection: effect of estrogen on cell proliferation and c-myc expression Mol. Cell. Endocrinol. 78 1991 61 69
15. Z.Q. Ma, E. Spreafico, G. Pollio, S. Santagati, E. Conti, E. Cattaneo and A. Maggi Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line Proc. Natl. Acad. Sci. USA 90 1993 3740 3744
16. S.Y. Jiang and V.C. Jordan Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor J. Natl. Cancer Inst. 84 1992 580 591
17. J.P. Issa, Y.L. Ottaviano, P. Celano, S.R. Hamilton, N.E. Davidson and S.B. Baylin Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon Nat. Genet. 7 1994 536 540
18. J. Brolin, L. Skoog and P. Ekman Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue Prostate 20 1992 281 295
19. A. Hobisch, A. Hittmair, G. Daxenbichler, S. Wille, C. Radmayr, P. Hobisch-Hagen, G. Bartsch, H. Klocker and Z. Culig Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors [see comments] J. Pathol. 182 1997 356 361
20. C. Sonnenschein, N. Olea, M.E. Pasanen and A.M. Soto Negative controls of cell proliferation: human prostate cancer cells and androgens Cancer Res. 49 1989 3474 3481
21. N. Konishi, S. Nakaoka, Y. Hiasa, Y. Kitahori, M. Ohshima, S. Samma and E. Okajima Immunohistochemical evaluation of estrogen receptor status in benign prostatic hypertrophy and in prostate carcinoma and the relationship to efficacy of endocrine therapy Oncology 50 1993 259 263
22. L.C. Li, R. Chui, K. Nakajima, B.R. Oh, H.C. Au and R. Dahiya Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression Cancer Res. 60 2000 702 706
23. Y.L. Ottaviano, J.P. Issa, F.F. Parl, H.S. Smith, S.B. Baylin and N.E. Davidson Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells Cancer Res. 54 1994 2552 2555
24. J.P. Issa, S.B. Baylin and S.A. Belinsky Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure Cancer Res. 56 1996 3655 3658
25. J.P. Issa, B.A. Zehnbauer, C.I. Civin, M.I. Collector, S.J. Sharkis, N.E. Davidson, S.H. Kaufmann and S.B. Baylin The estrogen receptor CpG island is methylated in most hematopoietic neoplasms Cancer Res. 56 1996 973 977
26. W.S. Post, P.J. Goldschmidt-Clermont, C.C. Wilhide, A.W. Heldman, M.S. Sussman, P. Ouyang, E.E. Milliken and J.P. Issa Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system Cardiovasc. Res. 43 1999 985 991
27. J.P. Issa, N. Ahuja, M. Toyota, M.P. Bronner and T.A. Brentnall Accelerated age-related CpG island methylation in ulcerative colitis Cancer Res. 61 2001 3573 3577
28. D.F. Gleason and G.T. Mellinger Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging J. Urol. 111 1974 58 64
29. R. Dahiya, C. Lee, J. McCarville, W. Hu, G. Kaur and G. Deng High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma Int. J. Cancer 72 1997 762 767
30. L.C. Li and R. Dahiya MethPrimer: designing primers for methylation PCRs Bioinformatics 18 2002 1427 1431
31. C.L. Paul and S.J. Clark Cytosine methylation: quantitation by automated genomic sequencing and GENESCAN analysis Biotechniques 21 1996 126 133
32. M. Gardiner-Garden and M. Frommer CpG islands in vertebrate genomes J. Mol. Biol. 196 1987 261 282
33. S.J. Clark, J. Harrison, C.L. Paul and M. Frommer High sensitivity mapping of methylated cytosines Nucleic Acids Res. 22 1994 2990 2997
34. C.L. Hsieh Dependence of transcriptional repression on CpG methylation density Mol. Cell. Biol. 14 1994 5487 5494
35. J.F. Costello, B.W. Futscher, K. Tano, D.M. Graunke and R.O. Pieper Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells J. Biol. Chem. 269 1994 17228 17237
36. A.P. Bird and A.P. Wolffe Methylation-induced repression-belts, braces, and chromatin Cell 99 1999 451 454
37. M. Toyota, N. Ahuja, M. Ohe-Toyota, J.G. Herman, S.B. Baylin and J.P. Issa CpG island methylator phenotype in colorectal cancer Proc. Natl. Acad. Sci. USA 96 1999 8681 8686